From: Immune monitoring after pediatric liver transplantation – the prospective ChilSFree cohort study
Basic patient data | |
Age | |
Sex | |
Weight & height at transplantation | |
Primary diagnosis | |
Comorbidities before transplantation | |
Concomitant medication at time of transplantation | |
Biochemistry and hematology before transplantation | |
Transplant-related data | |
Indication for transplantation | |
Type (split / whole liver) and weight of graft | |
Living related transplantation | |
Donor information: age, gender, cause of donor death | |
Blood group compatibility | |
HLA status recipient | |
Infection related data | |
CMV and EBV status of donor and recipient | |
EBV/CMV infection | |
Immunosuppression | |
Use of basiliximab for induction; IS drugs and trough levels at every visit, changes in IS drugs and reason for changes | |
Complications | |
Standardized documentation of portal vein stenosis, portal vein thrombosis, arterial stenosis, artherial thrombosis, sepsis, hepatic vein stenosis, biliary obstruction, bile leak, wound infection, prolonged ventilation, inotrope support, PTLD; additional documentation of “other” complications | |
Follow-up visits | |
Weight, height, biochemistry, hematology, virology (viral load CMV / EBV), changes in immunosuppressive medication, immunosuppressive drugs (dose and trough level), additional medication, additional comments | |
Biopsy visits | |
Results of liver biopsy (rejection none, mild, moderate, severe and RAI score) |